Why Is ENOVIS CORP (ENOV) Stock Up Today?

Enovis Corp shares climbed 16.90% to $24.42 on Wednesday. The primary driver was the company's third-quarter 2026 earnings report, which featured an adjusted EPS of $0.88, beating the consensus estimate of $0.77. The stock also printed 26 fresh 52-week highs on November 4.

What Happened

Enovis filed a Form 8-K on November 5, 2026, disclosing its financial results. Third-quarter sales grew 2% on a reported basis and 5% organically. Reconstructive sales increased 6% on both a reported and organic basis. Total sales of $558.725 million exceeded the $557.010 million estimate.

The company raised its full-year 2026 adjusted EPS guidance from a range of $3.52 to $3.73 to a new range of $3.58 to $3.79. This compares to the prior consensus estimate of $3.63. Full-year sales guidance was narrowed from $2.310 billion to $2.370 billion to a tighter range of $2.320 billion to $2.350 billion, against a consensus estimate of $2.339 billion. Needham maintained a Buy rating on the stock while lowering its price target to $34.

What The Data Shows

The stock has moved 15.4% over the last eight sessions, rising from $21.16 to $24.42. The 52-week range is $16.70 to $32.41. Enovis has a market cap of $1.2 billion and a beta of 1.42. The company is currently unprofitable with a trailing twelve-month EPS of -19.19 and a net margin of -48.0%. Revenue has grown 4.9% over the trailing twelve months.

Insider activity shows three buys totaling $450,000 in the last 90 days, with no sells. CEO Damien McDonald and Chief Administrative Officer Oliver Engert both purchased shares on September 4, 2026. Congressional trades show one sale of $1,001 to $15,000 by Donald J. Trump on June 4, 2026, with no buys in the last 90 days.

What To Watch

Enovis is scheduled to announce its fourth-quarter 2026 earnings results in early 2027. Investors will monitor whether the company can sustain its organic growth momentum and meet its raised full-year guidance.